ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 2 filers reported holding ALLENA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,000 | -16.7% | 25,000 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $6,000 | -60.0% | 25,000 | 0.0% | 0.01% | -58.3% |
| Q4 2021 | $15,000 | -50.0% | 25,000 | -24.2% | 0.01% | -47.8% |
| Q3 2021 | $30,000 | +11.1% | 33,000 | +57.1% | 0.02% | +9.5% |
| Q2 2021 | $27,000 | -32.5% | 21,000 | -27.6% | 0.02% | -38.2% |
| Q1 2021 | $40,000 | -20.0% | 29,000 | -25.6% | 0.03% | -26.1% |
| Q4 2020 | $50,000 | – | 39,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VII & Co. Ltd. | 2,263,365 | $15,889,000 | 50.04% |
| TRV GP II, LLC | 2,790,964 | $19,593,000 | 12.78% |
| FRAZIER MANAGEMENT LLC | 3,330,373 | $23,379,000 | 5.63% |
| Partner Investment Management, L.P. | 296,961 | $2,085,000 | 2.41% |
| SPHERA FUNDS MANAGEMENT LTD. | 431,193 | $3,027,000 | 0.28% |
| PFM Health Sciences, LP | 1,463,208 | $10,272,000 | 0.23% |
| Perceptive Advisors | 132,300 | $929,000 | 0.03% |
| Fosun International Ltd | 29,877 | $209,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 83,200 | $584,000 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 343,574 | $2,412,000 | 0.01% |